Skip to content

Author

Yan-Ni Xu

We have 2 of 85 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Novel SIRT1 Up-regulator F1462 Attenuates Endothelial Cell Senescence and Vascular Aging by Promoting Mitochondrial Biogenesis via Activating the SIRT1/PGC-1α/TFAM Pathway.

F1462 alleviates vascular EC senescence and vascular aging by boosting mitochondrial biogenesis through activation of the SIRT1/PGC-1α/TFAM axis, therefore representing a promosing candidate for the treatment of vascular aging and associated CVDs.

Shun-Wang Li, X. Zuo, Chao Liu et al. · 0 citations
Open access Aug 2026

A Novel Cell-Based High-Throughput Screening Model for Inhibitors Targeting Influenza Virus Hemagglutinin–α-2,6-Sialic Acid Interaction

This subtype-independent, highly specific high-throughput screening (HTS) model provides an efficient and reliable platform for early-stage influenza drug discovery and lead compound development.

Ke-Yu Guo, Xiao-Fang Chen, Chen-Yin Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.